Screener
Royalty Pharma RPRX Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on the most recent quarter.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's book value per share?
- Royalty Pharma (RPRX) reported book value per share of $17.57 in Q2 2026.
- How has Royalty Pharma's book value per share changed year-over-year?
- Royalty Pharma's book value per share increased by 4.1% year-over-year, from $16.88 to $17.57.
- What is the long-term trend for Royalty Pharma's book value per share?
- Over 5 years (2020 to 2025), Royalty Pharma's book value per share has grown at a -8.2% compound annual growth rate (CAGR), from $26.36 to $17.21.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Royalty Pharma's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude